Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

214
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

283
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
283
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

789
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
789

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Tuberculosis in Poland in 2023.

Przeglad epidemiologiczny·2026
Same author

Tuberculosis in Poland in 2021.

Przeglad epidemiologiczny·2024
Same author

Inventory study on completeness of tuberculosis case notifications in Poland in 2018.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024
Same author

Tuberculosis incidence in foreign-born people residing in European countries in 2020.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2023
Same author

Cladribine treatment in patients with pulmonary Langerhans cell histiocytosis.

Polish archives of internal medicine·2023
Same author

The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study.

Frontiers in public health·2023
Same journal

Infectious diseases in Poland in 2023.

Przeglad epidemiologiczny·2026
Same journal

Foodborne infections and intoxications in Poland in 2021-2023.

Przeglad epidemiologiczny·2026
Same journal

Salmonellosis in Poland in 2023.

Przeglad epidemiologiczny·2026
Same journal

Pertussis in Poland in 2023.

Przeglad epidemiologiczny·2026
Same journal

Lyme disease in Poland in 2023.

Przeglad epidemiologiczny·2026
See all related articles

Related Experiment Video

Updated: May 21, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K

Tuberculosis in Poland in 2022.

Maria Joanna Korzeniewska-Koseła1, Stefan Wesołowski2

  • 1Zakład Epidemiologii i Organizacji Walki z Gruźlicą, Instytut Gruźlicy i Chorób Płuc, Warszawa.

Przeglad Epidemiologiczny
|March 18, 2025
PubMed
Summary
This summary is machine-generated.

Tuberculosis incidence in Poland increased by 17.5% in 2022, with higher rates in men and older adults. Poland shows better bacteriological confirmation and lower multidrug-resistant tuberculosis rates than EU/EEA countries.

Keywords:
TB confirmed by cultureTB incidencedrug resistancegruźlicalekoopornośćpotwierdzenie bakteriologicznetuberculosis (TB)zapadalność

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K

Related Experiment Videos

Last Updated: May 21, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Tuberculosis (TB) remains a significant global health challenge.
  • Understanding current TB epidemiology is crucial for effective control strategies.

Purpose of the Study:

  • To analyze the 2022 tuberculosis epidemiology in Poland.
  • To compare Poland's TB data with European Union and European Economic Area (EU/EEA) countries.

Main Methods:

  • Analysis of registered TB cases in Poland for 2022.
  • Inclusion of drug susceptibility results and mortality data.
  • Comparison with European Centre for Disease Prevention and Control (ECDC) reports.

Main Results:

  • Poland registered 4314 TB cases in 2022 (11.4 per 100,000), a 17.5% increase from 2021.
  • Bacteriological confirmation rate was 81.9%, higher than the EU/EEA average (70.6%).
  • Multidrug-resistant TB (MDR-TB) was lower in Poland (3.1%) compared to EU/EEA (4.4%).

Conclusions:

  • TB incidence in Poland is rising, particularly among older males.
  • Poland demonstrates strengths in TB case confirmation and lower MDR-TB rates compared to EU/EEA.
  • Data gaps in HIV co-infection and treatment outcomes require attention for comprehensive TB control.